Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
9.73
-1.13 (-10.41%)
At close: Dec 20, 2024, 4:00 PM
9.98
+0.25 (2.57%)
After-hours: Dec 20, 2024, 6:53 PM EST
Jupiter Neurosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | - | - | 0.23 | 0.64 | 1.13 | - |
Revenue Growth (YoY) | - | - | -63.44% | -43.35% | - | - |
Cost of Revenue | 0.68 | 0.95 | 0.94 | 1.45 | 1.64 | 0.69 |
Gross Profit | -0.68 | -0.95 | -0.71 | -0.81 | -0.52 | -0.69 |
Selling, General & Admin | 2.43 | 2.92 | 2.72 | 3.1 | 1.34 | 1.49 |
Operating Expenses | 2.43 | 2.92 | 2.72 | 3.1 | 1.34 | 1.49 |
Operating Income | -3.12 | -3.87 | -3.43 | -3.91 | -1.85 | -2.18 |
Interest Expense | -0.25 | -0.22 | -0.74 | -0.11 | -0.01 | -0.32 |
Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non Operating Income (Expenses) | 0.11 | 0.19 | 0.26 | -0.09 | 0.28 | 0.3 |
EBT Excluding Unusual Items | -3.26 | -3.9 | -3.91 | -4.11 | -1.58 | -2.2 |
Other Unusual Items | 0.73 | -0.89 | -1.05 | -0.09 | -0.07 | -0.85 |
Pretax Income | -2.52 | -4.78 | -4.96 | -4.2 | -1.65 | -3.05 |
Net Income | -2.52 | -4.78 | -4.96 | -4.2 | -1.65 | -3.05 |
Net Income to Common | -2.52 | -4.78 | -4.96 | -4.2 | -1.65 | -3.05 |
Shares Outstanding (Basic) | 27 | 26 | 25 | 24 | 22 | 21 |
Shares Outstanding (Diluted) | 27 | 26 | 25 | 24 | 22 | 21 |
Shares Change (YoY) | 3.55% | 3.75% | 6.69% | 9.51% | 5.01% | - |
EPS (Basic) | -0.09 | -0.18 | -0.19 | -0.18 | -0.08 | -0.15 |
EPS (Diluted) | -0.09 | -0.18 | -0.19 | -0.18 | -0.08 | -0.15 |
Free Cash Flow | -0.5 | -0.48 | -1.25 | -1.74 | -0.25 | -0.14 |
Free Cash Flow Per Share | -0.02 | -0.02 | -0.05 | -0.07 | -0.01 | -0.01 |
Gross Margin | - | - | - | -126.90% | -45.74% | - |
Operating Margin | - | - | -1471.38% | -612.36% | -164.41% | - |
Profit Margin | - | - | -2125.15% | -658.31% | -146.92% | - |
Free Cash Flow Margin | - | - | -535.19% | -271.94% | -22.62% | - |
EBIT | -3.12 | -3.87 | -3.43 | -3.91 | -1.85 | -2.18 |
EBIT Margin | - | - | - | - | -164.41% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.